Cargando…
The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023
The routine use of whole genome sequencing (WGS) as a reference typing technique for Mycobacterium tuberculosis epidemiology combined with the catalogued and extensive knowledge base of resistance-associated mutations means an initial susceptibility prediction can be derived from all cultured isolat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383358/ https://www.ncbi.nlm.nih.gov/pubmed/37512981 http://dx.doi.org/10.3390/microorganisms11071809 |
_version_ | 1785080890017185792 |
---|---|
author | Anthony, Richard Groenheit, Ramona Mansjö, Mikael de Zwaan, Rina Werngren, Jim |
author_facet | Anthony, Richard Groenheit, Ramona Mansjö, Mikael de Zwaan, Rina Werngren, Jim |
author_sort | Anthony, Richard |
collection | PubMed |
description | The routine use of whole genome sequencing (WGS) as a reference typing technique for Mycobacterium tuberculosis epidemiology combined with the catalogued and extensive knowledge base of resistance-associated mutations means an initial susceptibility prediction can be derived from all cultured isolates in our laboratories based on WGS data alone. Preliminary work has confirmed, in our low-burden settings, these predictions are for first-line drugs, reproducible, robust with an accuracy similar to phenotypic drug susceptibility testing (pDST) and in many cases able to also predict the level of resistance (MIC). Routine screening for drug resistance by WGS results in approximately 80% of the isolates received being predicted as fully susceptible to the first-line drugs. Parallel testing with both WGS and pDST has demonstrated that routine pDST of genotypically fully susceptible isolates yields minimal additional information. Thus, rather than re-confirming all fully sensitive WGS-based predictions, we suggest that a more efficient use of available mycobacterial culture capacity in our setting is the development of a more extensive and detailed pDST targeted at any mono or multi-drug-resistant isolates identified by WGS screening. Phenotypic susceptibility retains a key role in the determination of an extended susceptibility profile for mono/multi-drugresistant isolates identified by WGS screening. The pDST information collected is also needed to support the development of future catalogues of resistance-associated mutations. |
format | Online Article Text |
id | pubmed-10383358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103833582023-07-30 The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 Anthony, Richard Groenheit, Ramona Mansjö, Mikael de Zwaan, Rina Werngren, Jim Microorganisms Review The routine use of whole genome sequencing (WGS) as a reference typing technique for Mycobacterium tuberculosis epidemiology combined with the catalogued and extensive knowledge base of resistance-associated mutations means an initial susceptibility prediction can be derived from all cultured isolates in our laboratories based on WGS data alone. Preliminary work has confirmed, in our low-burden settings, these predictions are for first-line drugs, reproducible, robust with an accuracy similar to phenotypic drug susceptibility testing (pDST) and in many cases able to also predict the level of resistance (MIC). Routine screening for drug resistance by WGS results in approximately 80% of the isolates received being predicted as fully susceptible to the first-line drugs. Parallel testing with both WGS and pDST has demonstrated that routine pDST of genotypically fully susceptible isolates yields minimal additional information. Thus, rather than re-confirming all fully sensitive WGS-based predictions, we suggest that a more efficient use of available mycobacterial culture capacity in our setting is the development of a more extensive and detailed pDST targeted at any mono or multi-drug-resistant isolates identified by WGS screening. Phenotypic susceptibility retains a key role in the determination of an extended susceptibility profile for mono/multi-drugresistant isolates identified by WGS screening. The pDST information collected is also needed to support the development of future catalogues of resistance-associated mutations. MDPI 2023-07-14 /pmc/articles/PMC10383358/ /pubmed/37512981 http://dx.doi.org/10.3390/microorganisms11071809 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Anthony, Richard Groenheit, Ramona Mansjö, Mikael de Zwaan, Rina Werngren, Jim The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 |
title | The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 |
title_full | The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 |
title_fullStr | The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 |
title_full_unstemmed | The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 |
title_short | The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023 |
title_sort | relative positioning of genotyping and phenotyping for tuberculosis resistance screening in two eu national reference laboratories in 2023 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383358/ https://www.ncbi.nlm.nih.gov/pubmed/37512981 http://dx.doi.org/10.3390/microorganisms11071809 |
work_keys_str_mv | AT anthonyrichard therelativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT groenheitramona therelativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT mansjomikael therelativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT dezwaanrina therelativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT werngrenjim therelativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT anthonyrichard relativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT groenheitramona relativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT mansjomikael relativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT dezwaanrina relativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 AT werngrenjim relativepositioningofgenotypingandphenotypingfortuberculosisresistancescreeningintwoeunationalreferencelaboratoriesin2023 |